Legal Representation
Attorney
Richard J. Groos
USPTO Deadlines
Next Deadline
510 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2006-12-05)
Due Date
December 05, 2026
Grace Period Ends
June 05, 2027
Application History
50 events| Date | Code | Type | Description |
|---|---|---|---|
| Mar 6, 2025 | RNWL | P | INTERNATIONAL REGISTRATION RENEWED |
| Nov 14, 2019 | ADCH | M | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| Mar 2, 2018 | INNP | P | PARTIAL INVALIDATION PROCESSED BY THE IB |
| Feb 8, 2018 | INPS | P | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |
| Feb 8, 2018 | INPC | P | INVALIDATION PROCESSED |
| Feb 5, 2018 | INPR | P | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED |
| Sep 27, 2017 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Jun 5, 2017 | NA71 | E | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED |
| Jun 5, 2017 | 71AG | O | REGISTERED-SEC.71 ACCEPTED |
| Jun 1, 2017 | ES71 | I | TEAS SECTION 71 RECEIVED |
| Nov 24, 2016 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED |
| Dec 5, 2015 | REM4 | E | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED |
| Jul 16, 2015 | RNWL | P | INTERNATIONAL REGISTRATION RENEWED |
| Jul 20, 2013 | INPR | P | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED |
| Nov 20, 2012 | NA75 | E | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED |
| Nov 20, 2012 | C75P | O | REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK. |
| Nov 20, 2012 | 715F | I | REGISTERED - SEC. 71 & SEC. 15 FILED |
| Nov 20, 2012 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Oct 23, 2012 | ES75 | I | TEAS SECTION 71 & 15 RECEIVED |
| Mar 28, 2008 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Jul 11, 2007 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB |
| Jul 11, 2007 | FIMP | P | FINAL DISPOSITION PROCESSED |
| Jul 6, 2007 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Dec 5, 2006 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Sep 19, 2006 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Aug 30, 2006 | NPUB | O | NOTICE OF PUBLICATION |
| Aug 8, 2006 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Aug 8, 2006 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Jul 28, 2006 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Jul 21, 2006 | ALIE | A | ASSIGNED TO LIE |
| Jul 19, 2006 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Jun 30, 2006 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Jun 26, 2006 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Jun 26, 2006 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Jun 13, 2006 | ATRV | O | ATTORNEY REVIEW COMPLETED |
| Jun 13, 2006 | CREV | I | CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED |
| Jun 6, 2006 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| May 25, 2006 | RINX | P | USPTO CORRECTION PROCESSED BY IB |
| May 25, 2006 | CRCV | M | CORRECTION TRANSACTION RECEIVED FROM IB |
| Apr 27, 2006 | CORR | I | CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED |
| Apr 27, 2006 | DMCC | I | DATA MODIFICATION COMPLETED |
| Apr 27, 2006 | CPRA | O | PRIORITY ACTION MAILED |
| Apr 26, 2006 | CPRA | R | PRIORITY ACTION WRITTEN |
| Apr 13, 2006 | CRCV | M | CORRECTION TRANSACTION RECEIVED FROM IB |
| Apr 12, 2006 | ACEC | I | AMENDMENT FROM APPLICANT ENTERED |
| Apr 3, 2006 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Apr 3, 2006 | I | PAPER RECEIVED | |
| Oct 28, 2005 | RFNT | P | REFUSAL PROCESSED BY IB |
| Oct 13, 2005 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Oct 13, 2005 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Detailed Classifications
Class 005
[ Pharmaceutical preparations, namely, anti-allergic preparations and substances, pharmaceutical preparations for the treatment of erectile dysfunction; pharmaceutical preparations for acting on the central nervous system, pharmaceutical preparations for the treatment of gastro-intestinal diseases; pharmaceutical preparations for animal skin care, pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; pharmaceutical preparations for ocular or intraocular surgery; ] pharmaceutical preparations for skin care; [ pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; pharmaceutical preparations for treating allergic rhinitis; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for wounds; pharmaceutical products and preparations against dry skin caused by pregnancy; pharmaceutical products and preparations for chloasma; pharmaceutical products and preparations for hydrating the skin during pregnancy; pharmaceutical products and preparations for pregnancy blemishes; pharmaceutical products and preparations for preventing skin blemishes during pregnancy; pharmaceutical products and preparations to prevent stretch marks; pharmaceutical products and preparations to prevent swelling; pharmaceutical products for ophthalmological use; pharmaceutical products for skin care of animals; pharmaceutical products for the treatment of bone diseases; pharmaceutical products for the treatment of viral and infectious diseases; pharmaceutical products for treating respiratory diseases; pharmaceutical skin lotions; pharmaceutical solutions used in dialysis; dental composite materials; magnetic bracelets for medical purposes; oiled papers for medical purposes; pharmaceutical wafers made out of starches in papery membrane for wrapping a dose of powdered medicine; gauze for dressings; gelatin capsules soled empty for pharmaceuticals; eye patches, adhesive bandages for the ear, incontinence diapers; semen for artificial insemination; menstruation bandages, menstruation tampons, sanitary napkins and pads for menstruation, menstruation panties and knickers; absorbent cotton for medical purposes; powdered milk for babies; nutritional supplements, namely, lactose; fly catching paper; adhesive plaster for medical purposes, bandages for dressings; collodion for medical purposes, namely, for use in fixing bandages or covering an affected wound; mothproofing paper; breast pads ]
Additional Information
Color Claim
Color is not claimed as a feature of the mark.
Translation
THE ENGLISH TRANSLATION OF THE WORD SHISEIDO IN THE MARK IS "HEAVENLY".
Classification
International Classes
005
USPTO Documents
Click to view cached USPTO documents for this trademark
Only administrators can request new documents from USPTO